Norac Pharma

Norac Pharma is a long-established, private contract research and manufacturing organization (CRAMO) focused on API process development and supply for the pharmaceutical industry. Its core business model is providing fee-for-service chemistry, analytical, and manufacturing support to biopharma clients, particularly in early-phase drug development and for niche, complex molecules including controlled substances. The company leverages over 50 years of experience, a comprehensive suite of facilities from kilo labs to pilot plants, and a client-centric partnership approach to compete in the competitive CRAMO market. Its recent SOCMA award and facility expansion indicate ongoing investment in operational excellence and capacity.

Integrated API service platform specializing in complex synthetic chemistry, including controlled substances (Schedule 1-3) and potent compounds. Capabilities encompass process R&D, analytical R&D, cGMP manufacturing from kilo to pilot scale, and full regulatory support.

Norac Pharma competes in the fragmented Contract Research, Development, and Manufacturing Organization (CRDMO) market. It differentiates through deep expertise in controlled substances and potent compounds, a client-partnership model, and US-based operations. Key competitors range from large global players (Lonza, Catalent) to specialized chemistry-focused CDMOs, both domestic and international.